Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Common Equity (2020 - 2024)

Historic Common Equity for IceCure Medical (ICCM) over the last 5 years, with Q4 2024 value amounting to $6.9 million.

  • IceCure Medical's Common Equity fell 4326.24% to $6.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $6.9 million, marking a year-over-year decrease of 4326.24%. This contributed to the annual value of $6.9 million for FY2024, which is 4326.24% down from last year.
  • As of Q4 2024, IceCure Medical's Common Equity stood at $6.9 million, which was down 4326.24% from $12.2 million recorded in Q4 2023.
  • IceCure Medical's 5-year Common Equity high stood at $27.0 million for Q4 2021, and its period low was $5.6 million during Q4 2020.
  • In the last 5 years, IceCure Medical's Common Equity had a median value of $12.2 million in 2023 and averaged $15.4 million.
  • Its Common Equity has fluctuated over the past 5 years, first soared by 37730.17% in 2021, then tumbled by 5215.56% in 2023.
  • Quarter analysis of 5 years shows IceCure Medical's Common Equity stood at $5.6 million in 2020, then skyrocketed by 377.3% to $27.0 million in 2021, then fell by 5.7% to $25.4 million in 2022, then tumbled by 52.16% to $12.2 million in 2023, then crashed by 43.26% to $6.9 million in 2024.
  • Its Common Equity stands at $6.9 million for Q4 2024, versus $12.2 million for Q4 2023 and $25.4 million for Q4 2022.